Cabasag, Jose S.
HRN: 24-12-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2023
METRONIDAZOLE 500MG (TAB)
11/21/2023
11/28/2023
PO
750mg
TID
Amoebiasis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes